Literature DB >> 14766241

Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis.

Beth Y Karlan.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14766241     DOI： 10.1016/j.ygyno.2003.12.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.

Authors:  Susan M Domchek; Tara M Friebel; Judy E Garber; Claudine Isaacs; Ellen Matloff; Rosalind Eeles; D Gareth Evans; Wendy Rubinstein; Christian F Singer; Stephen Rubin; Henry T Lynch; Mary B Daly; Jeffrey Weitzel; Patricia A Ganz; Gabriella Pichert; Olufunmilayo I Olopade; Gail Tomlinson; Nadine Tung; Joanne L Blum; Fergus Couch; Timothy R Rebbeck
Journal:  Breast Cancer Res Treat       Date:  2010-02-24       Impact factor: 4.872

2.  Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.

Authors:  B E Kiely; M L Friedlander; R L Milne; L Stanhope; P Russell; M A Jenkins; P Weideman; S A McLachlan; P Grant; J L Hopper; K A Phillips
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 3.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.